Evaluating glycaemic control in patients poorly controlled on oral antidiabetic drugs in real-world setting: Results from assessing the Appropriate Timing of Type 2 diAbetes INtensification (ATTAIN).

Jude, Edward B; O'Leary, Caroline; Myland, Melissa; Nixon, Mark; Gooch, Nick; Shaunik, Alka; Lew, Elisheva

Jude, Edward B; O'Leary, Caroline; Myland, Melissa; Nixon, Mark; Gooch, Nick; Shaunik, Alka; Lew, Elisheva.

Afiliación

Jude EB; Diabetes Centre Tameside General Hospital Ashton-under-Lyne UK.
O'Leary C; IQVIA London UK.
Myland M; IQVIA London UK.
Nixon M; IQVIA London UK.
Gooch N; Sanofi Guildford UK.
Shaunik A; Sanofi Bridgewater NJ USA.
Lew E; Sanofi Chilly-Mazarin France.

Endocrinol Diabetes Metab ; 3(1): e00094, 2020 Jan.

Article en En | MEDLINE | ID: mdl-31922021

Palabras clave

adherence; electronic medical records; glycaemic control; oral antidiabetic drugs; realworld study; treatment intensification; type 2 diabetes melitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Endocrinol Diabetes Metab Año: 2020 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google